List of works - Manuel Vázquez-Carrera

Ageing introduces a complex pattern of changes in several rat brain transcription factors depending on gender and anatomical localization

scientific article published on 4 April 2006

Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.

scientific article published on 12 November 2007

Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A

scientific journal article

Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages

scientific article published on May 2004

CDK11 Promotes Cytokine-Induced Apoptosis in Pancreatic Beta Cells Independently of Glucose Concentration and Is Regulated by Inflammation in the NOD Mouse Model

publication published on 10 February 2021

Down-regulation of acyl-CoA oxidase gene expression and increased NF-kappaB activity in etomoxir-induced cardiac hypertrophy.

scientific article

Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II.

scientific article published in September 2003

Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice

scientific article

Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells

scientific article

Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21

scientific article published on 23 May 2019

PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice.

scientific article

PPAR-β/δ activation promotes phospholipid transfer protein expression.

scientific article

PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.

scientific article published on 9 November 2010

PPARβ/δ and lipid metabolism in the heart.

scientific article published on 26 January 2016

PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.

scientific article

Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation

scientific article published on 01 October 2006

Peroxisome proliferator-activated receptor alpha down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy

scientific article published on 01 December 2007

Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients

scientific article published on 09 December 2014

Role of brain c-Jun N-terminal kinase 2 in the control of the insulin receptor and its relationship with cognitive performance in a high-fat diet pre-clinical model

scientific article published on 27 March 2019

Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism

scientific article published on 16 August 2004

SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2

scientific article published on 10 September 2020

SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation

scientific article published on 28 February 2020

TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model

scientific article

The Interplay between NF-kappaB and E2F1 Coordinately Regulates Inflammation and Metabolism in Human Cardiac Cells ⬇️

scientific article published on May 23, 2011

The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1 ⬇️

scientific article published on December 10, 2010

List of works by Manuel Vázquez-Carrera

Ageing introduces a complex pattern of changes in several rat brain transcription factors depending on gender and anatomical localization

Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.

Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A

Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages

CDK11 Promotes Cytokine-Induced Apoptosis in Pancreatic Beta Cells Independently of Glucose Concentration and Is Regulated by Inflammation in the NOD Mouse Model

Down-regulation of acyl-CoA oxidase gene expression and increased NF-kappaB activity in etomoxir-induced cardiac hypertrophy.

Down-regulation of acyl-CoA oxidase gene expression in heart of troglitazone-treated mice through a mechanism involving chicken ovalbumin upstream promoter transcription factor II.

Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice

Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells

Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21

PGC-1beta down-regulation is associated with reduced ERRalpha activity and MCAD expression in skeletal muscle of senescence-accelerated mice.

PPAR-β/δ activation promotes phospholipid transfer protein expression.

PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.

PPARβ/δ and lipid metabolism in the heart.

PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.

Palmitate-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation

Peroxisome proliferator-activated receptor alpha down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy

Remarkable quantitative and qualitative differences in HDL after niacin or fenofibrate therapy in type 2 diabetic patients

Role of brain c-Jun N-terminal kinase 2 in the control of the insulin receptor and its relationship with cognitive performance in a high-fat diet pre-clinical model

Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism

SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2

SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation

TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model

The Interplay between NF-kappaB and E2F1 Coordinately Regulates Inflammation and Metabolism in Human Cardiac Cells ⬇️

The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1 ⬇️